NEOPHOTONICS CORP — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d28df7c1-1477-4437-9418-b3ca6265d231/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $290.3M | 2021-01-01 – 2021-12-31 | evidence 0001227025-22-000014 |
| FY 2020 | $371.2M | 2020-01-01 – 2020-12-31 | evidence 0001227025-21-000034 |
| FY 2019 | $356.8M | 2019-01-01 – 2019-12-31 | evidence 0001227025-20-000020 |
| FY 2018 | $322.5M | 2018-01-01 – 2018-12-31 | evidence 0001227025-19-000013 |
| FY 2017 | $292.9M | 2017-01-01 – 2017-12-31 | evidence 0001227025-19-000013 |
| FY 2016 | $411.4M | 2016-01-01 – 2016-12-31 | evidence 0001227025-19-000013 |
| FY 2015 | $339.4M | 2015-01-01 – 2015-12-31 | evidence 0001558370-16-004127 |
| FY 2014 | $306.2M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001751 |
| FY 2013 | $282.2M | 2013-01-01 – 2013-12-31 | evidence 0001564590-14-002398 |
| FY 2012 | $245.4M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-110074 |
| FY 2011 | $201.0M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-143139 |
| FY 2010 | $177.7M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-143139 |
| FY 2009 | $145.3M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-143139 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NEOPHOTONICS CORP — all facts · Net Income · Operating Income